Patient Safety news and information

URAC, a Washington-based healthcare measurement and accreditation organization, has named Kylanne Green president and CEO, effective July 22. Green succeeds Alan Spielman, who left his post Feb. 15 after serving as president and CEO since 2005. Green, a nurse practitioner, previously...
FULL STORY »

Celebrities drive average Americans to want what they have. That powerful impulse can even influence grave healthcare decisions and could prove complicated for women who fear they're at high risk for breast cancer after Angelina Jolie's disclosure that she underwent a preventive double...
FULL STORY »

Modern Healthcare reporter Maureen McKinney talks with Michael Tarwater, CEO of Carolinas HealthCare System, Charlotte, N.C.
FULL STORY »

Patrick Lukulay faced a daunting task this month when he stepped off a plane in Accra, Ghana. Local clinics were reporting that oxytocin, a drug used to stop hemorrhaging after childbirth, was no longer working.
FULL STORY »

The orthopedic unit of Johnson & Johnson said that it was phasing out production of all-metal replacement hips, a move reflecting an industrywide trend to abandon the once widely used implants because of high early failure rates.
FULL STORY »

Cancer researchers are growing increasingly enthusiastic about harnessing the body's own immune system to fight tumors.
FULL STORY »

The Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones.
FULL STORY »

Maintaining moderation in sodium consumption is key, according to a new Institute of Medicine report that supported past research and reiterated that high salt intake could cause heart disease, but which also warned that reducing salt intake below recommended dietary guidelines could be harmful.
FULL STORY »

A new study is questioning the benefits of dual-chamber implantable cardioverter-defibrillators.
FULL STORY »

The Indian generic drugmaker Ranbaxy, which already operates under an unprecedented consent decree banning sales of many of its products in the U.S., agreed to plead guilty in federal court and pay $500 million to resolve allegations of shoddy factory inspections and poor quality control.
FULL STORY »